Science AdvancesNeurosciencePeer-reviewed journal article
Astrocytic RNA editing regulates the host immune response to alpha-synuclein
Karishma D’SaiD, Minee L. ChoiiD, Aaron Z. WageniD, Núria Setó‐SalviaiD, Olga KopachiD, James R. EvansiD, Margarida RodriguesiD, Patricia Lopez-GarciaiD, Joanne LachicaiD, Benjamin E. ClarkeiD, Jaijeet SinghiD, Ali E. GhareebiD, James BayneiD, Melissa Grant‐PetersiD, Sonia García-RuiziD, Zhongbo CheniD, Samuel G. RodriquesiD, Dilan S. AthaudaiD, Emil Karl GustavssoniD, Sarah A. Gagliano TaliuniD, Christina E. ToomeyiD, Regina Hertfelder ReynoldsiD, George R. YoungiD, Stephanie StrohbueckeriD, Thomas T. WarneriD, , Mina RyteniD
Abstract
RNA editing is a post transcriptional mechanism that targets changes in RNA transcripts to modulate innate immune responses. We report the role of astrocyte specific, ADAR1 mediated RNA editing in neuroinflammation in Parkinsons disease. We generated hiPSC-derived astrocytes, neurons and co-cultures and exposed them to small soluble alpha-synuclein aggregates. Oligomeric alpha-synuclein triggered an inflammatory glial state associated with TLR activation, viral responses, and cytokine secretion. This reactive state resulted in loss of neurosupportive functions, and the induction of neuronal toxicity. Notably, interferon response pathways were activated leading to upregulation, and isoform switching of the RNA deaminase enzyme, ADAR1. ADAR1 mediates A-to-I RNA editing, and increases in RNA editing were observed in inflammatory pathways in cells, as well as in post-mortem human PD brain. Aberrant, or dysregulated, ADAR1 responses and RNA editing may lead to sustained inflammatory reactive states in astrocytes triggered by alpha-synuclein aggregation, and this may drive the neuroinflammatory cascade in Parkinsons.
- organism: human
- assay: bulk RNA-seq
- research focus: differential expression
- research focus: gene regulatory network inference
- research focus: cell-cell communication
- approach: statistical model
- approach: experimental assay
- Citations
- 16
- FWCI
- 4.48
- Field percentile
- top 4%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Astrocyte-Specific dsRNA-ADAR1 Signalling Links Innate Immunity to Complement Activation in Parkinson Disease
Yang Liu, Glenda Margaret Halliday, YuHong Fu·bioRxiv·Oct 12, 2026
- Alterations in RNA editing in skeletal muscle following exercise training in individuals with Parkinsons disease
Heather Mercer, Aiswarya Mukundan Nair, … Helen Piontkivska·bioRxiv·May 30, 2023
- Fibrillar α-synuclein induces neurotoxic astrocyte activation via RIP kinase signaling and NF-κB
Tsui-Wen Chou, Nydia P. Chang, … Brian P. Daniels·Cell Death and DiseasePeer-reviewed·Jul 31, 2021
- The Potential Regulation of A-to-I RNA editing on Genes in Parkinson's Disease
Sijia Wu, Qiuping Xue, … Liyu Huang·GenesPeer-reviewed·Apr 15, 2023
- Constitutively active STING causes neuroinflammation and degeneration of dopaminergic neurons in mice
Éva M. Szegő, Laura Malz, … Hella Luksch·eLifePeer-reviewed·Oct 31, 2022
- The role of ADAR editing and nonsense-mediated decay in Parkinson's Disease
Heather Mercer, Aiswarya Mukundan Nair, … Helen Piontkivska·bioRxiv·May 17, 2024